Citation Impact
Citing Papers
Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis
2013
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
2009 Standout
Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
2014
Unraveling oxyntomodulin, GLP1's enigmatic brother
2012
Bariatric Surgery for Weight Loss and Glycemic Control in Nonmorbidly Obese Adults With Diabetes
2013
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction
2002
Progress and challenges in anti-obesity pharmacotherapy
2017
Diagnostic Usefulness and Prognostic Implications of the Mitral E/E′ Ratio in Patients With Heart Failure and Severe Secondary Mitral Regurgitation
2007
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2008 Standout
The scent of disease: volatile organic compounds of the human body related to disease and disorder
2011 Standout
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials
2012
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes
2012
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
2014
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Global epidemiology and outcomes of acute kidney injury
2018 Standout
A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries
2015
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The Role of Echocardiography in the Diagnosis and Management of Heart Failure
2003
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Mitral regurgitation in patients with advanced systolic heart failure
2004
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
2015
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Type 2 diabetes
2017 Standout
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
The Future of Peptide‐based Drugs
2012 Standout
Peptide therapeutics: current status and future directions
2014 Standout
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
2014
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Significant Mitral Regurgitation Left Untreated at the Time of Aortic Valve Replacement
2014
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
Type 2 diabetes mellitus
2015 Standout
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
2019
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Polycystic ovary syndrome
2016 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
European Guidelines for Obesity Management in Adults
2015 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
Evaluation of left ventricular function and mitral regurgitation during left ventricular‐based pacing in patients with heart failure
2001
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Efficacy and safety of glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: A systematic review and mixed‐treatment comparison analysis
2016
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Current and emerging medications for overweight or obesity in people with comorbidities
2015
Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy
2016
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Analysis of acidic metabolites by capillary column GC and GC/MS
1983
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
2013
Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
2015
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis
2017
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
New and Emerging Drug Molecules Against Obesity
2013
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
2014
Atherosclerotic Plaque Healing
2020
Natural product and natural product derived drugs in clinical trials
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Effectiveness of N ‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
2016
Surgery for weight loss in adults
2014 Standout
Role of nitric oxide in the functional response to ischemia-reperfusion of heart mitochondria from hyperthyroid rats
2004
Cardiovascular Actions of Incretin-Based Therapies
2014
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Quantitative Proteome Analysis Reveals Increased Content of Basement Membrane Proteins in Arteries From Patients With Type 2 Diabetes Mellitus and Lower Levels Among Metformin Users
2015
Determinants of the Degree of Functional Mitral Regurgitation in Patients With Systolic Left Ventricular Dysfunction
2000
Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus
2014
Works of Anders Junker being referenced
2012 ESC STEMI guidelines and reperfusion therapy
2013
Influence of Ezetimibe on Plaque Morphology in Patients with ST Elevation Myocardial Infarction Assessed by Optical Coherence Tomography: An OCTIVUS Sub-Study
2019
Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients
2007
The Hemodynamic and Prognostic Significance of Echo-Doppler-Proven Mitral Regurgitation in Patients with Dilated Cardiomyopathy
1993
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
2012
Impact of Diabetes on Clinical Outcomes after Revascularization with Everolimus- and Sirolimus-Eluting Stents
2011
Prevention of Contrast-Induced Nephropathy With N-Acetylcysteine or Sodium Bicarbonate in Patients With ST-Segment–Myocardial Infarction
2014
2-Methyl-3-oxovaleriansäure: ein charakteristischer metabolit bei propionacidämie
1980